A new Alameda County pilot program called the Scalable Housing Investment Funding Toolkit, or SHIFT, seeks to make more housing for less money with an innovative, first-in-the-state approach to ...

A new Alameda County pilot program called the Scalable Housing Investment Funding Toolkit, or SHIFT, seeks to make more housing for less money with an innovative, first-in-the-state approach to ...

FDA sought policy recommendations on mental health medical devices, including AI-enabled. After I reviewed submissions, one ...

Tom Hancock, a portfolio manager at GMO, favors companies that consistently earn a high return on capital and reinvest in the ...

Intellectual property (IP) agreements are the backbone of innovation and business strategy. They govern ownership, licensing, and enforcement ...

For a few moments that evening, the spotlight focused on Ms. Stavros of Pickering, Ont. She was the first in the country who ...

Three Republican-led states have challenged the Food and Drug Administration’s (FDA) approval of a generic form of the abortion pill mifepristone earlier this year, arguing the agency’s decision had ...

Vyvanse, or its generic counterpart lisdexamfetamine dimesylate, is prescribed to treat ADHD in adults, and children six years of age or older, as well as moderate to sever binge eating disorder (BED) ...

The definition of TV continues to evolve as consumer behavior changes. What is considered TV has moved beyond cable or streaming programming and has creeped into short form and social content as well.

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...

The Food and Drug Administration said it will be taking steps to speed up the approval process for developing generic biological drugs, an effort aimed at increasing cheaper competition among ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...